Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 5/20 | 0.57 |
| ▸ | MBOAT4 | Q96T53 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24129144 | 0.85 | MBOAT4 (0.51) | ENPP1MBOAT4ALDH1A1 | |
| SCHEMBL2462145 | 0.83 | ENPP1 (0.61) | ENPP1MBOAT4ALDH1A1GAAPOLB | |
| SCHEMBL24127885 | 0.75 | ENPP1 (0.59) | ENPP1MBOAT4ALDH1A1LMNAGAA | |
| SCHEMBL22968380 | 0.74 | MBOAT4 (0.71) | ENPP1MBOAT4 | |
| SCHEMBL2582203 | 0.74 | ENPP1 (0.51) | ENPP1MBOAT4ALDH1A1GAAL3MBTL1 | |
| SCHEMBL24127923 | 0.73 | ENPP1 (0.57) | ENPP1MBOAT4ALDH1A1LMNAGAA | |
| SCHEMBL24129256 | 0.73 | MBOAT4 (0.50) | ENPP1MBOAT4ALDH1A1POLBTSHR | |
| SCHEMBL5324250 | 0.73 | MBOAT4 (0.40) | ENPP1MBOAT4ALDH1A1LMNAGAA | |
| SCHEMBL22968411 | 0.72 | MBOAT4 (1.00) | MBOAT4 | |
| SCHEMBL5226752 | 0.72 | MBOAT4 (0.67) | ENPP1MBOAT4ALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063729-A1 | Microbiocides | BAYER CROPSCIENCE K. K. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1345940-A2 | TRIAZOLOPYRIMIDINES | Bayer CropScience K.K. (JP) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002051845-A2 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE K.K. (DE) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063729-A1 | Microbiocides | FPR1, MPO, FPR2 | ENPP1 929/4885MBOAT4 2808/4885ALDH1A1 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.